# Nuclide record radiant-3-4 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/radiant-3-4/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "radiant-3-4", "NCT00510068" ;
  schema:name "RADIANT-3 and RADIANT-4"@en ;
  schema:description "The two trials that made everolimus a standard pill for pancreatic, lung and gut neuroendocrine tumours."@en ;
  schema:url <https://nuclide.cc/trials/radiant-3-4/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00510068> ;
  nuclide:status "positive" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/pancreatic-net/>, <https://nuclide.cc/indications/small-intestinal-net/>, <https://nuclide.cc/indications/lung-net/> ;
  nuclide:drugs <https://nuclide.cc/drugs/everolimus/> .